Jane Street Group, LLC Jazz Pharmaceuticals PLC Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

A detailed history of Jane Street Group, LLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Jane Street Group, LLC holds 132,422 shares of JAZZ stock, worth $16.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
132,422
Previous 213,991 38.12%
Holding current value
$16.8 Million
Previous $22.8 Million 35.38%
% of portfolio
0.0%
Previous 0.03%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$100.57 - $116.37 $8.2 Million - $9.49 Million
-81,569 Reduced 38.12%
132,422 $14.8 Million
Q2 2024

Aug 14, 2024
BUY
$103.94 - $118.98 $9.8 Million - $11.2 Million
94,322 Added 78.82%
213,991 $22.8 Million
Q1 2024

May 15, 2024
SELL
$115.19 - $132.77 $18.3 Million - $21.1 Million
-158,721 Reduced 57.01%
119,669 $14.4 Million
Q4 2023

Feb 14, 2024
BUY
$114.26 - $136.0 $21.9 Million - $26 Million
191,530 Added 220.5%
278,390 $34.2 Million
Q3 2023

Nov 14, 2023
BUY
$122.0 - $145.31 $5.9 Million - $7.03 Million
48,374 Added 125.69%
86,860 $11.2 Million
Q2 2023

Aug 14, 2023
BUY
$122.5 - $147.16 $2.62 Million - $3.15 Million
21,414 Added 125.43%
38,486 $4.77 Million
Q1 2023

May 15, 2023
SELL
$133.98 - $160.47 $6.58 Million - $7.88 Million
-49,088 Reduced 74.2%
17,072 $2.5 Million
Q4 2022

Feb 14, 2023
BUY
$129.72 - $159.85 $7.97 Million - $9.82 Million
61,410 Added 1292.84%
66,160 $10.5 Million
Q3 2022

Nov 14, 2022
SELL
$126.59 - $161.18 $1.31 Million - $1.67 Million
-10,379 Reduced 68.6%
4,750 $634,000
Q3 2022

Nov 14, 2022
SELL
$126.59 - $161.18 $1.31 Million - $1.67 Million
-10,379 Reduced 68.6%
4,750 $634,000
Q2 2022

Aug 16, 2022
SELL
$141.59 - $168.66 $4.46 Million - $5.32 Million
-31,523 Reduced 67.57%
15,129 $2.36 Million
Q1 2022

May 17, 2022
BUY
$129.64 - $160.7 $3.21 Million - $3.98 Million
24,775 Added 113.25%
46,652 $7.26 Million
Q4 2021

Feb 15, 2022
SELL
$119.87 - $145.67 $6.78 Million - $8.24 Million
-56,593 Reduced 72.12%
21,877 $2.79 Million
Q3 2021

Nov 16, 2021
BUY
$128.64 - $184.79 $7.13 Million - $10.2 Million
55,418 Added 240.4%
78,470 $10.2 Million
Q2 2021

Aug 16, 2021
BUY
$160.2 - $186.42 $2.05 Million - $2.38 Million
12,766 Added 124.11%
23,052 $4.1 Million
Q1 2021

May 18, 2021
SELL
$150.19 - $173.5 $11.6 Million - $13.4 Million
-77,370 Reduced 88.27%
10,286 $1.69 Million
Q4 2020

Feb 17, 2021
BUY
$140.71 - $165.05 $8.61 Million - $10.1 Million
61,161 Added 230.84%
87,656 $14.5 Million
Q3 2020

Nov 17, 2020
SELL
$105.46 - $144.13 $2.63 Million - $3.6 Million
-24,981 Reduced 48.53%
26,495 $3.78 Million
Q2 2020

Aug 17, 2020
BUY
$95.68 - $121.88 $4.65 Million - $5.93 Million
48,630 Added 1708.71%
51,476 $5.68 Million
Q1 2020

May 15, 2020
SELL
$87.74 - $152.74 $94,145 - $163,890
-1,073 Reduced 27.38%
2,846 $284,000
Q4 2019

Feb 14, 2020
SELL
$117.65 - $153.73 $323,890 - $423,218
-2,753 Reduced 41.26%
3,919 $585,000
Q3 2019

Nov 14, 2019
BUY
$125.18 - $143.24 $638,543 - $730,667
5,101 Added 324.7%
6,672 $855,000
Q2 2019

Aug 15, 2019
SELL
$125.55 - $144.48 $962,340 - $1.11 Million
-7,665 Reduced 82.99%
1,571 $224,000
Q1 2019

May 16, 2019
BUY
$121.81 - $142.95 $668,127 - $784,080
5,485 Added 146.23%
9,236 $1.32 Million
Q4 2018

Feb 15, 2019
BUY
$115.94 - $166.74 $246,140 - $353,989
2,123 Added 130.41%
3,751 $465,000
Q1 2018

May 15, 2018
BUY
$135.59 - $157.16 $220,740 - $255,856
1,628 New
1,628 $246,000
Q4 2017

Feb 15, 2018
SELL
$131.06 - $150.39 $336,693 - $386,351
-2,569 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$142.62 - $155.6 $366,390 - $399,736
2,569
2,569 $376,000

Others Institutions Holding JAZZ

# of Institutions
511
Shares Held
57.7M
Call Options Held
188K
Put Options Held
133K
View Full List

About Jazz Pharmaceuticals plc

JAZZ Quotes by TradingView
  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.94B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email